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Medicines made in the pharmacies by the 
individual doctor’s prescription from the point of view of 
biopharmaceuticals are much more effective than similar 
drugs manufactured in industrial conditions [1]. 
Therefore, extemporal medicines are still relevant, 
especially for inpatient facilities, since the existing range 
of ready-made drugs can not fully meet the needs of 
patients, since there are such drugs that are not produced 
by pharmaceutical companies at all for various reasons 
[2, 3]. An example of this can be the drugs for children 
and newborns [4, 5]. 
Statement of the problem in general, relevance of the 
topic and its connection with important scientific or 
practical issues 
Production of drugs in pharmacies has many 
advantages [6], so that patients can receive extemporal 
medicines to the needs of a particular patient, its 
diagnosis, age, individual sensitivity and intolerance to 
individual components. However, the production of 
extemporal medicines requires the presence of a relevant 
production base and qualified staff at the pharmacy [7, 
8]. 
Analysis of recent researches and publications in 
which the solution to this problem initiated and on 
which the author relies 
Previously, the authors developed an 
organizational and legal procedure for the circulation of 
drugs: prescription and OTC drugs [2], combined drug 
and precursor drugs [5], as well as licensing activities of 
drugs’ circulation [8], the definition of nomenclature and 
legal [5], the classification and legal groups, the control 
regime, the scientific information and analytical program 
"NIAP" regarding the qualification of the control regime 
for medicines of various classification and normative 
groups [7]. 
Selection of previously unsettled parts of the general 
problem, which is devoted to the article 
Today, in Ukraine, there is no clear-cut 
organizational and legal procedure of the circulation of 
extemporal medicines; therefore, issues related to its 
development, especially at the stage of quality control, 
remain relevant. Ensuring the quality of extemporal 
medicines involves meeting the relevant requirements for 
workers and requiring highly skilled professional 
knowledge, skills and abilities. As the profession of 
pharmacist is becoming more and more important today, 
the issue of improving of the professionalism and 
competence of pharmacists, in particular the definition of 
the professional status of an authorized person at the 
stage of quality control of extemporal medicines in their 
circulation in healthcare establishments remains a topical 
issue. 
Formulating the goals (tasks) of the article 
The purpose of the study was to work out the 
organizational and legal procedure for regulating of the 
circulation of extemporal medicines by developing an 
algorithm for the definition of a normative and legal act, 
which used by an authorized person in the event of a 
conflict of law in the pharmaceutical legislation. 
Presentation of the main research material (methods 
and objects) with the justification of the results 
The materials of the study were legal acts of 
Ukraine: Laws of Ukraine (3), Decrees of the Cabinet of 
Ministers of Ukraine (3), Orders of the Ministry of 
Healthcare of Ukraine (5). The research methods were 
legal, documentary and comparative analyzes. 
Results of the research and their discussion. 
Based on the conducted research, an organization and 
legal procedure was developed for regulating of the 
circulation of extemporal medicines and proposed an 
algorithm for the determination of the normative and 
legal act, which used by an authorized person at the stage 
of quality control of extemporal medicines (Figure 1). 
The proposed algorithm worked out in determining the 
status of an authorized person in the healthcare instituion, 
involved in the production of the extemporal medicines 
(pharmacies, hospitals). In case of inconsistency between 
the current normative acts of Ukraine, their contradiction 
with the same subject of regulation, as well as the 
contradiction between formally operating norms of law 
adopted on the same issue, which in the legal sphere is 
defined as a conflict of law, then a question arises on the 
necessity of choosing a normative act used by an 
authorized person which apply to a specific case. 
Important to recall that in Ukraine, a quality system has 
been introduced and functioning, developed in 
accordance with the requirements of the international 
pharmaceutical inspection cooperation system (PIC/S); 
WHO; the national standard DSTU ISO 9001:2009 
licensing of the activities of the circulation of medicines 
[8, 9]. A compulsory component of the quality system is 
the presence of an authorized person in the healthcare 
institutions. Particular importance is the position of an 
authorized person healthcare instituions of private 
property, in staffing lists who do not have the position of 
pharmacist-analyst. In such healthcare instituions, the 
extemporal medicines circulation at the quality control 
stage must perform with the help of an authorized person.
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Figure 1 – Algorithm of the definition of a normative and legal act, which used in the accidence of a conflict of 
law with respect to the regulation of the circulation of extemporal medicines 
 
It should be noted that in the EU countries, the 
designation of an authorized person is a prerequisite for 
obtaining a license for the circulation of medicines 
(stages: the manufacture of medicines, the production of 
extemporal medicines), and the change in the personal 
composition of an authorized person is impossible 
without prior agreement with the licensing authority. 
Thus, in accordance with the requirements of the GMP, 
an authorized person appointed from the management of 
the healthcare institution and is responsible for the 
organization and operation of the quality system, 
granting permission for the implementation of each series 
of drugs, participates in the development of quality 
control guidelines, etc. [10]. 
Guided by the developed algorithm, we will 
analyze the professional status of an authorized person at 
the stage of quality control of extemporal medicines in 
their circulation in the healthcare institutions of private 
ownership. Established that this issue regulated by 
several normative documents. Paragraph 5.1 of the order 
of the Ministry of Healthcare of Ukraine dated 
17.10.2012 No. 812 "On approval of the Rules for 
production (manufacturing) and quality control of the 
medicines in pharmacies" in relation to the qualification 
requirements for an authorized person specifies next. 
Pharmacies, involved in production (manufacturing) of 
medicines must have a staff member who have an 
appropriate special education and meet the same 
qualification requirements. Paragraph 5.7 determines that 
"Pharmacist-analyst carries out systematic supervision of 
the technological process of production (manufacturing) 
of medicines and instructs persons who participate in it". 
At the same time, paragraph 5.6 of this order states that 
"An authorized person must possess all types of internal 
pharmacy quality control of produced (manufactured) 
medicines and in the matter of absence of pharmacist-
analyst to ensure its implementation". Consequently, 
there are no qualifying requirements for an authorized 
person in this order. 
Subsequently, while studying the order of the 
Ministry of Healthcare of Ukraine dated 09.29.2014 No. 
677 "On approval of the procedure for the control of the 
quality of medicines in the wholesale and retail trade" 
regarding the qualification requirements for an 
authorized person, we established the following. An 
authorized person must be a specialist with a complete 
higher pharmaceutical education and the work 
experience in the specialty of at least 2 years. 
Additionally, the subject of economic activity assigns 
responsibilities for the effective management of the 
quality system of medicines in their wholesale and retail 
sales, the conduct of input quality control of the drugs, in 
particular extemporal medicines to an authorized person 
[11, 12]. 
Performing duties of an authorized person 
responsible for the effective management of the quality 
system of the medicines in healthcare institutions, located 
in the countryside, can be relied upon a person with a 
pharmaceutical education who has acquired an 
educational qualification level of a specialist  junior 
specialist, bachelor. An authorized person’s duties in 
rural areas can be relied upon specialists without 
professional experience [13]. 
At the same time, in the order of the Ministry of 
Healthcare of Ukraine dated 16.12.2003 No. 584 "On 
approval of the rules for the storage and conducting of 
quality control of medicines healthcare institutions", an 
authorized person defined as "specialist (head/senior 
nurse, pharmacist/pharmacy technician), appointed by 
the order of the head of the healthcare institution, which 
assigned the function of holding responsibility for the 
quality of the medicines that come to the healthcare 
institution"[14]. 
Step 1 
Determine, which body 
issued a normative act 
Step 2a 
If issued by the same body, 
determine act’s legal validity 
Step 2b 
If issued by different bodies, 
determine their authority in 
hierarchy of state bodies 
Step 3a 
If similar by legal validity, 
determine approval date 
Step 3b 
If not similar by legal 
validity, use act with 
higher power 
Step 3 
Use an act, issued by the 
higher authority 
Step 4 
Newer norm has priority 
Step 5 
Special legal act 
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The main purpose of an authorized person’s 
activity is to provide an adequate level of quality of 
medicines from the moment of their actual receipt, during 
the storage and their medical application. Such actions 
are aimed at preventing the use of counterfeit, poor-
quality and unregistered medicines [9, 10]. On this issue 
analyzed the provisions of the order of the Ministry of 
Healthcare of Ukraine dated 31.10.2011 No. 723 "On 
approval of licensing conditions for conducting 
economic activities for the production of medicines, 
wholesale and retail trade of medicines" (in the edition 
of the order of the Ministry of Healthcare of Ukraine 
dated 22.12.2014 No. 990). Indicated there, that an 
authorized person is a "person who has a diploma in the 
field of pharmaceutical education issued by educational 
institutions of the III-IV accreditation levels and a 
certificate of assignment (confirmation) of the rank of a 
pharmacy specialist or certified in this specialty with an 
assignment (confirmation) of the qualification category 
and has experience of work in the specialty "Pharmacy" 
at least 2 years (quality assurance of medicines in the 
pharmacy located in a village, settlement, urban-type 
settlement can be relied on a person holding a diploma of 
the pharmaceutical education issued by educational 
institutions of the I- II levels of accreditation, or a person 
who has received a bachelor's degree in educational 
institutions of the III-IV accreditation levels without 
experience in the specialty "Pharmacy"), to which 
assigned responsibilities for the functioning of the system 
of quality assurance of medicines in their wholesale and 
retail trade». 
Also, in the above-mentioned order specified 
the particularities of the professional status of an 
authorized person in healthcare institutions who engaged 
in the industrial production of medicines  this should be 
"a specialist with a complete higher pharmaceutical, 
chemical, biological or biotechnological education and 
experience in the profession of at least 2 years in the field 
of production, quality control, or the creation of a 
medicines who is entrusted with the responsibilities for 
the functioning of the system of quality assurance of 
medicines in their production and granting a permit for 
the issuance (realization) of the medicines". 
Consequently, the last document specifies the 
qualification requirements for a specialist, which can 
hold the functions of an authorized person. 
With the help of the developed algorithm (Fig. 
1), we will select a normative and legal act, which guides 
in determining of the professional status of an authorized 
person. First, determine which authority issued the 
normative act (Step 1). The aforementioned normative 
documents issued by the Ministry of Healthcare of 
Ukraine, that is, by the same body. Next, we establish the 
legal validity of the researched documents (Step 2a): 
these are orders, that is, they are equal to each other by 
legal force. The next step is to clarify the timing of the 
adoption of these orders (Step 3a). We use the rule (Step 
4) that the priority is the normative document (Step 5) 
issued later (even if the act previously adopted has not 
lost its validity). Important to note that such a 
disagreement might arise from the fact that the adoption 
of the latest norm not always accompanied by the 
abolition of previous rules on the same issue. 
With the help of the developed algorithm 
established that when determining the professional status 
of an authorized person, which has a diploma in 
pharmaceutical education of educational institutions of 
the III-IV levels of accreditation and a certificate of 
assignment (confirmation) of the rank of specialist 
pharmacist or certified in this specialty with the 
assignment (confirmation) of the qualification category 
and has experience of work on the specialty "Pharmacy" 
not less than 2 years (quality assurance of medicines in a 
pharmacy located in a village, settlement, urban-type 
settlement, can rely on a person holding a diploma ro 
pharmaceutical education of educational institutions of 
the I-II levels of accreditation, or a person who has 
received a bachelor's degree in educational institutions of 
III-IV accreditation levels, without experience in the 
specialty "Pharmacy"), who is entrusted with the 
responsibilities for the operation of the quality assurance 
system of extemporal medicines with their wholesale and 
retail trade", necessary to follow the provisions of the 
order of the Ministry of Healthcare of Ukraine dated 
22.12.2014 No. 990 "On amendments to certain orders 
of the Ministry of Healthcare of Ukraine". 
As can be seen from Fig. 1, in the event of a 
mismatch between acts issued by the same body, but 
having different legal force, an act of higher legal force 
is applied (Step 3b). For example, in case of divergence 
of the norms of the law and the Constitution of Ukraine 
adopted by the Verkhovna Rada of Ukraine, the conflict 
is resolved in favor of the Constitution, which has the 
highest legal force. In the event of a difference between 
the acts adopted by the various bodies in place in the 
hierarchical structure (Step 2b)  higher and lower, an act 
adopted by the supreme body as having greater legal 
force is applied (Step 3). In addition, in case of 
divergence between general and special legal acts, the 
advantage given to a special one, if not abolished by 
issued later general act [15]. 
As an example, let us consider the issue of 
determining the validity of the license for business in the 
pharmaceutical industry. Thus, an Article 13 (paragraph 
12) of the Law of Ukraine "On licensing of types of 
economic activities" states, "The license is issued for an 
unlimited period". Article 7 (paragraph 10) of the same 
Law stipulates that licensed production of medicines, 
wholesale and retail trade in medicines, and the import of 
medicines (except for active pharmaceutical ingredients) 
are subject to licensing. The licensing procedure is 
carried out taking into account the specifics defined by 
the Law of Ukraine "On medicines". At the same time, in 
paragraph 22 of this article noted the activity of 
cultivating plants included in Table I of the List of 
narcotic drugs, psychotropic substances and precursors, 
approved by the Cabinet of Ministers of Ukraine, the 
development, production, manufacture, storage, 
transportation, purchase, sale (release), the importation 
into the territory of Ukraine, export from the territory of 
Ukraine, the use, destruction of narcotic drugs, 
psychotropic substances and precursors included in the 
above List, carried out taking into account the 
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particularities defined by the Law of Ukraine "On 
narcotic drugs, psychotropic substances and 
precursors". Consequently, while determining the term 
of the license for the circulation of narcotic drugs, 
psychotropic substances and precursors, the special legal 
act, that is, the Law of Ukraine "On narcotic drugs, 
psychotropic substances and precursors", where Article 8 
states that "The license for the conduct of activity in the 
circulation of narcotic drugs, psychotropic substances 
and precursors is issued for five years". 
Conclusions from the conducted research and 
prospects of further development of this direction 
On the principles of pharmaceutical law, 
developed an organizational and legal procedure to 
regulate the circulation of the extemporal medicines. An 
algorithm proposed for the definition of normative and 
legal act, which used in the practical activities of an 
authorized person. Reviewed the professional status of an 
authorized person at the stage of quality control of 
extemporal medicines on the stage of their circulation in 
private healthcare institutions. Determined the the main 
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UDC 615.014.2:340.6:343.294 
ORGANIZATIONAL AND LEGAL 
REGULATION PROCEDURE FOR 
CIRCULATION OF EXTEMPORAL MEDICINES 
BASED ON PHARMACEUTICAL LAW 
Shapovalov V. V., Zbrozhek S. I.,  
Shapovalova V. O., Shapovalov V. V. 
Introduction. The paper studied the situation regarding 
the production of medicines in pharmacies. Established 
that the presence of the pharmacy manufacture of 
medicines, patients entitled to receive medicines made 
to the needs of individuals. Goal – to study the 
organizational and legal procedure of regulation of 
extemporal medicines by developing of the algorithm 
for determining the legal act used in the event of 
conflict based on the law pharmaceutical law. Materials 
and methods. The materials of the study were legal acts 
of Ukraine: Laws of Ukraine, Decrees of the Cabinet of 
Ministers of Ukraine, Orders of the Ministry of 
Healthcare of Ukraine. The research methods were 
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legal, documentary and comparative analyzes. Results 
and discussion. However, production of 
extemporaneous preparations in the pharmacy requires a 
production base and the appropriate staff. Therefore, the 
authors based on pharmaceutical law proposed 
organizational and legal procedure regarding the 
regulation of extemporaneous preparations by 
developing the algorithm for determining the legal act 
which should follow in the event of conflicts concerning 
the law. Conclusions. Based on pharmaceutical law 
held organizational and legal procedure for the 
regulation of circulation of extemporal medicines. 
Proposed the algorithm for determining of the legal act 
used in the practice of pharmacy professionals. 
Considered the professional status of an authorized 
person on the stage of quality control of extemporal 
medicines in their treatment in healthcare institutions of 
private property. 
Keywords: the legal procedure, circulation, 
extemporal medicines, pharmaceutical law. 
